{"id":252636,"date":"2024-12-17T23:03:06","date_gmt":"2024-12-17T22:03:06","guid":{"rendered":"https:\/\/r3i.org\/folleto-pcsk9-y-aterosclerosis\/"},"modified":"2025-02-05T21:46:26","modified_gmt":"2025-02-05T20:46:26","slug":"folleto-pcsk9-y-aterosclerosis","status":"publish","type":"page","link":"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/","title":{"rendered":"Folleto : PCSK9 y Aterosclerosis"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bb8a9a809c-7a33-46fa-a9c3-6cbb2909b12a\u00bb background_image=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Design-sans-titre.png\u00bb parallax=\u00bbon\u00bb custom_padding=\u00bb1vw||1vw||true|false\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22background_color_gradient_stops%22%93}\u00bb][et_pb_row column_structure=\u00bb2_3,1_3&#8243; _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb2_3&#8243; _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbFolletos\u00bb _builder_version=\u00bb4.27.3&#8243; _module_preset=\u00bba97d2c6e-7b99-4859-b03c-bd1a8625b1d7&#8243; title_font=\u00bbPoppins||||||||\u00bb title_text_align=\u00bbleft\u00bb title_text_color=\u00bb#FFFFFF\u00bb title_font_size=\u00bb65px\u00bb custom_margin=\u00bb||10px||false|false\u00bb text_shadow_style=\u00bbpreset1&#8243; global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_2,1_2&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/Screenshot-2024-12-17-at-23.04.53.png\u00bb title_text=\u00bbCaptura de pantalla 2024-12-17 a las 23.04.53&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_2&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb header_2_text_color=\u00bbgcid-primary-color\u00bb header_3_text_color=\u00bbgcid-primary-color\u00bb custom_margin=\u00bb||3px|||\u00bb global_colors_info=\u00bb{%22gcid-primary-color%22:%91%22quote_text_color%22,%22header_2_text_color%22,%22header_3_text_color%22%93}\u00bb]<\/p>\n<h3 style=\"text-align: center;\"><span>PCSK9 y aterosclerosis<\/span><\/h3>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb header_6_text_color=\u00bb#000000&#8243; global_colors_info=\u00bb{}\u00bb]<\/p>\n<h6 style=\"text-align: center;\">Por los profesores Jean Davignon, Jean-Charles Fruchart y Michel Hermans<\/h6>\n<p>[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/r3i.org\/wp-content\/uploads\/2024\/12\/PCSK9__Atherosclerosis_booklet.pdf\u00bb button_text=\u00bbDescargar folleto\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_button][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb14px\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span>Creado por los profesores Jean Davignon , Jean-Charles Fruchart y Michel Hermans, el paquete descargable de 242 diapositivas analiza el papel potencial de los mAbs anti-PCSK9 en el futuro tratamiento de las enfermedades cardiovasculares.<\/span><br \/><span> <\/span><br \/><span>Los autores revisan las necesidades no cubiertas en el tratamiento de la dislipidemia, el descubrimiento y la estructura de la PCSK9, los niveles de PCSK9 en la salud y la enfermedad, las interacciones PCSK9-f\u00e1rmaco centr\u00e1ndose en los ensayos con estatinas, los enfoques actuales de la inhibici\u00f3n de la PCSK9 y los resultados de los ensayos precl\u00ednicos y cl\u00ednicos con mAb anti-PCSK9.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PCSK9 y aterosclerosisPor los profesores Jean Davignon, Jean-Charles Fruchart y Michel HermansCreado por los profesores Jean Davignon , Jean-Charles Fruchart y Michel Hermans, el paquete descargable de 242 diapositivas analiza el papel potencial de los mAbs anti-PCSK9 en el futuro tratamiento de las enfermedades cardiovasculares. Los autores revisan las necesidades no cubiertas en el tratamiento [&hellip;]<\/p>\n","protected":false},"author":258497324,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_wpcom_ai_launchpad_about_page":false,"_wpcom_ai_launchpad_gallery_page":false,"_wpcom_ai_launchpad_contact_page":false,"_wpcom_ai_launchpad_events_page":false,"_wpcom_ai_launchpad_video_page":false,"_wpcom_ai_launchpad_portfolio_piece":false,"footnotes":""},"class_list":["post-252636","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Folleto : PCSK9 y Aterosclerosis - R3I<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Folleto : PCSK9 y Aterosclerosis - R3I\" \/>\n<meta property=\"og:description\" content=\"PCSK9 y aterosclerosisPor los profesores Jean Davignon, Jean-Charles Fruchart y Michel HermansCreado por los profesores Jean Davignon , Jean-Charles Fruchart y Michel Hermans, el paquete descargable de 242 diapositivas analiza el papel potencial de los mAbs anti-PCSK9 en el futuro tratamiento de las enfermedades cardiovasculares. Los autores revisan las necesidades no cubiertas en el tratamiento [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/\" \/>\n<meta property=\"og:site_name\" content=\"R3I\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T20:46:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/folleto-pcsk9-y-aterosclerosis\\\/\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/folleto-pcsk9-y-aterosclerosis\\\/\",\"name\":\"Folleto : PCSK9 y Aterosclerosis - R3I\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#website\"},\"datePublished\":\"2024-12-17T22:03:06+00:00\",\"dateModified\":\"2025-02-05T20:46:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/folleto-pcsk9-y-aterosclerosis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/r3i.org\\\/es\\\/folleto-pcsk9-y-aterosclerosis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/folleto-pcsk9-y-aterosclerosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/r3i.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Folleto : PCSK9 y Aterosclerosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"name\":\"R3I\",\"description\":\"Residual Risk Reduction Initiative\",\"publisher\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/r3i.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#organization\",\"name\":\"R3I\",\"url\":\"https:\\\/\\\/r3i.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/r3i.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/r3i.org\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1\",\"width\":1601,\"height\":834,\"caption\":\"R3I\"},\"image\":{\"@id\":\"https:\\\/\\\/r3i.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Folleto : PCSK9 y Aterosclerosis - R3I","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/","og_locale":"es_ES","og_type":"article","og_title":"Folleto : PCSK9 y Aterosclerosis - R3I","og_description":"PCSK9 y aterosclerosisPor los profesores Jean Davignon, Jean-Charles Fruchart y Michel HermansCreado por los profesores Jean Davignon , Jean-Charles Fruchart y Michel Hermans, el paquete descargable de 242 diapositivas analiza el papel potencial de los mAbs anti-PCSK9 en el futuro tratamiento de las enfermedades cardiovasculares. Los autores revisan las necesidades no cubiertas en el tratamiento [&hellip;]","og_url":"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/","og_site_name":"R3I","article_modified_time":"2025-02-05T20:46:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/","url":"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/","name":"Folleto : PCSK9 y Aterosclerosis - R3I","isPartOf":{"@id":"https:\/\/r3i.org\/es\/#website"},"datePublished":"2024-12-17T22:03:06+00:00","dateModified":"2025-02-05T20:46:26+00:00","breadcrumb":{"@id":"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/r3i.org\/es\/folleto-pcsk9-y-aterosclerosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r3i.org\/es\/"},{"@type":"ListItem","position":2,"name":"Folleto : PCSK9 y Aterosclerosis"}]},{"@type":"WebSite","@id":"https:\/\/r3i.org\/es\/#website","url":"https:\/\/r3i.org\/es\/","name":"R3I","description":"Residual Risk Reduction Initiative","publisher":{"@id":"https:\/\/r3i.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r3i.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/r3i.org\/es\/#organization","name":"R3I","url":"https:\/\/r3i.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/r3i.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/r3i.org\/wp-content\/uploads\/2024\/11\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1","contentUrl":"https:\/\/i0.wp.com\/r3i.org\/wp-content\/uploads\/2024\/11\/r3i-logo-transp-1.png?fit=1601%2C834&ssl=1","width":1601,"height":834,"caption":"R3I"},"image":{"@id":"https:\/\/r3i.org\/es\/#\/schema\/logo\/image\/"}}]}},"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/Pgbfv2-13IM","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/users\/258497324"}],"replies":[{"embeddable":true,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/comments?post=252636"}],"version-history":[{"count":1,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252636\/revisions"}],"predecessor-version":[{"id":252639,"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/pages\/252636\/revisions\/252639"}],"wp:attachment":[{"href":"https:\/\/r3i.org\/es\/wp-json\/wp\/v2\/media?parent=252636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}